Skip to content
    KREF
    Earnings call· Jun 2026(Q2 FY26)

    KKR Real Estate Finance Trust Inc. KREF

    Jul 22, 2026 Source

    Executive summary

    KKR Real Estate Finance Trust Q2 FY26 — Strategic Review Initiated Amidst Portfolio Repositioning

    KKR Real Estate Finance Trust announced a strategic review by its independent board, while reporting a significant book value decline due to reserve adjustments for legacy assets. Management believes the most substantial impact is behind them, as they continue to execute a portfolio repositioning plan focused on reducing legacy office and watchlist exposures, increasing newer vintage investments, and managing leverage back into target ranges. The company also noted progress in monetizing REO assets and expressed optimism for multifamily market tightening in the coming quarters.

    Highlights

    5

    • Reported distributable earnings before realized losses of $0.10 per share, covering the quarterly dividend.

    • Repurchased $38 million of common stock at a weighted average price of $6.63 per share, generating approximately $0.32 per share of book value accretion.

    • Received over $800 million of repayments during the quarter, contributing to liquidity.

    • New originations (2024-2026 vintage) increased to 32% of the portfolio, up from 19% at year-end 2025.

    • Life Science exposure modified increased to 39% from 19%, with the vast majority of expected reserves now recognized.

    Concerns

    5

    • Reported a GAAP loss of $122 million or negative $1.95 per share.

    • Book value declined 13.7% to $10.24 per share, primarily reflecting reserve adjustments for watch list assets and legacy office exposures.

    • Reported a distributable loss of $36 million or negative $0.58 per share.

    • Total leverage stood at 4.3x, exceeding the target range of 3.5x to 4x.

    • Downgraded Chicago office and Carrollton Multifamily loans from risk-rated 4 to 5, and a Dallas multifamily asset from risk-rated 3 to 4.

    Guidance & targets

    9
    CategoryTargetConfidence
    Annual dividend coverage
    $0.40 per year
    high materiality
    High
    Earnings trough
    later this year
    medium materiality
    Medium
    Legacy office exposure
    below 10%
    high materiality
    High
    Watchlist assets reduction
    complete reduction
    high materiality
    High
    Life Science exposure addressed
    substantially all
    medium materiality
    High
    Newer vintage investments (2024-2026)
    more than half of the portfolio
    high materiality
    High
    Total repayments
    exceed $2 billion
    high materiality
    High
    Total leverage
    move back into 3.5x to 4x
    high materiality
    Medium
    Mountain View REO monetization
    bring to market within the next year
    medium materiality
    Medium

    Operational metrics

    22
    Book value per share
    $10.24
    Q2 FY26

    As of June 30, 2026.

    Book value decline
    13.7%QoQ
    Q2 FY26

    Primarily reflecting actions taken to position watch list assets and legacy office exposures monetization.

    Distributable earnings before realized losses per share
    $0.10
    Q2 FY26

    Covered quarterly dividend.

    Dividend per share
    $0.10
    Q2 FY26

    Cash dividend paid with respect to the second quarter.

    Legacy office exposure
    18%down from 21% at year-end 2025
    Q2 FY26

    As of June 30, 2026.

    Watchlist assets as % of portfolio
    16%
    Q2 FY26

    As of June 30, 2026. Nearly half are currently being marketed.

    Life Science exposure modified
    39%up from 19%
    Q2 FY26

    Believe vast majority of expected reserves have now been recognized.

    New vintage investments (2024-2026)
    32%up from 19% as of 2025 year-end
    Q2 FY26

    Loans originated between 2024 and 2026.

    Repayments
    $800M
    Q2 FY26

    Received during the quarter.

    Repayments YTD
    $1.2B
    YTD FY26

    Received through the first 6 months.

    Common stock repurchased
    $38M
    Q2 FY26

    Generated approximately $0.32 per share of book value accretion.

    Common stock repurchased subsequent to quarter end
    $10M
    Subsequent to Q2 FY26

    Additional repurchases.

    Total liquidity
    >$700M
    Q2 FY26

    At quarter end.

    Cash on hand
    $83M
    Q2 FY26

    Included in total liquidity.

    Undrawn corporate revolver capacity
    $350M
    Q2 FY26

    Included in total liquidity.

    Total financing availability
    $7B
    Q2 FY26

    At quarter end.

    Undrawn financing capacity
    $2.6B
    Q2 FY26

    At quarter end.

    Non-mark-to-market financing
    79%
    Q2 FY26

    Of total financing.

    Debt-to-equity ratio
    2.6x
    Q2 FY26

    As of quarter end.

    Total leverage
    4.3x
    Q2 FY26

    As of quarter end, compared to target range of 3.5x to 4x.

    Originations
    $350M
    Q2 FY26

    Included a multifamily portfolio loan in Spain, a multifamily loan in Los Angeles, and a California office portfolio loan.

    Target ROE on new originations
    12%
    ongoing

    Consistent with historical targets for levered returns.

    Industry KPIs

    2
    MetricValueDetails
    Investment volume closed$350MUSD
    Ffo core ffo normalized ffo per share$0.10USD

    Deals & partnerships

    1
    KKR Real Estate Finance Trust BoardInitiation of a review of strategic alternatives to enhance shareholder value.

    The process will be led by a strategic review committee composed solely of the Board's independent directors. KKR has not submitted a proposal for any transaction to date but will evaluate potential participation. No further comments will be made at this early stage.

    Risks & headwinds

    5
    Book value declineQ2 FY26

    13.7% decline to $10.24 per share

    Mitigation: Adjusted reserves and carrying values to current expectations for monetization of watch list assets and legacy office exposures; management believes most significant impact is behind them.

    Earnings troughH2 FY26 and next several quarters

    Earnings expected to trough later this year

    Mitigation: Execution of business plan and portfolio repositioning expected to emerge as a benefit longer-term.

    Elevated total leverageQ2 FY26

    4.3x total leverage

    Mitigation: Expect total leverage to naturally move back into the target range of 3.5x to 4x as repayments continue.

    Loan downgradesQ2 FY26

    Chicago office and Carrollton Multifamily downgraded from risk-rated 4 to 5; Dallas multifamily from 3 to 4

    Mitigation: Proactive steps to align the portfolio with expectations for asset resolutions, including marketing nearly half of watchlist assets.

    Multifamily market softnessNear-term

    Higher rates and supply in Sunbelt putting pressure on values

    Mitigation: Optimistic for market tightening in occupancy and rents over the next few quarters as supply is digested; active management of credit risk.

    What to watch in Q3 FY26

    5

    Legacy office exposure reduction

    by year-end 2026
    Current18% of portfolio
    TargetBelow 10%

    Why it matters

    This is a key component of the portfolio repositioning strategy and crucial for book value stability.

    Legacy office exposure declined to 18% of the portfolio at June 30 compared to 21% at year-end 2025. We remain focused on reducing that exposure below 10% by year-end 2026.

    Q&A highlights

    7

    How is this quarter's loan loss review and book value assessment different from prior quarters, and what is the confidence level in book value stability?

    Management stated that the current quarter's book value decline reflects a discovery process of clearing values in the market and a more aggressive posture towards monetization. They believe the most significant impact to book value is behind them, though minor fluctuations are possible as resolutions finalize.

    “I think what we have now is we're in a number of processes. We're getting real-time market feedback around levels to sell these, and we're adjusting, obviously, our reserves or our marks accordingly.”

    asked by Tom Kathee · answered by Matthew Salem

    2 min read6 chapters

    Detailed Narrative

    01

    Strategic Alternatives Review Initiated

    The KKR Real Estate Finance Trust Board has initiated a review of strategic alternatives aimed at enhancing shareholder value. This process will be led by a strategic review committee composed solely of independent directors. While KKR, as the largest shareholder, is aligned with the committee's mandate, it has not submitted a proposal for any transaction to date and will evaluate potential participation in any future transaction.

    02

    Book Value Stability and Portfolio Repositioning

    Book value declined 13.7% during the quarter to $10.24 per share, primarily due to reserve adjustments and carrying value changes related to watch list assets and legacy office exposures. Management believes the most significant book value impact is now behind the company, positioning KREF for greater stability. The company is executing an action plan to reposition its portfolio, focusing on resolving legacy assets and increasing newer vintage investments.

    03

    Progress on Legacy Asset Reduction

    Legacy office exposure decreased to 18% of the portfolio at June 30, down from 21% at year-end 2025, with a target to reduce it below 10% by year-end 2026. Watchlist assets represent 16% of the portfolio, with nearly half currently being marketed for a complete reduction by year-end. Life Science exposure that has been modified increased to 39%, up from 19%, with the vast majority of expected reserves now recognized and a goal to address substantially all by year-end.

    04

    REO Portfolio Monetization Efforts

    The REO portfolio, valued at $658 million, is actively being managed for monetization. Progress includes completing the entitlement process for a mixed-use redevelopment project in Portland, Oregon, and closing the first condo sale in West Hollywood. The Mountain View, California asset, fully leased to Open AI, is anticipated to be brought to market within the next year. A Philadelphia office REO asset is currently in the market for liquidation this year, while Seattle and South Boston Life Science assets are considered longer-term resolutions.

    05

    Origination Activity and Capital Allocation

    The company originated three loans totaling approximately $350 million during the quarter, with a weighted average LTV of 58%. These included multifamily loans in Spain and Los Angeles, and a California office portfolio loan. New vintage investments (2024-2026) now constitute 32% of the portfolio, targeting over 50% by year-end. Repayments exceeded $800 million in the quarter, providing liquidity for new originations and share repurchases, with $38 million of common stock repurchased in Q2 and an additional $10 million post-quarter end.

    06

    Multifamily Market Trends and Credit Outlook

    Management acknowledged that the higher interest rate environment and significant supply in Sunbelt markets have put pressure on multifamily values, leading to some localized softness. However, they expressed optimism for a tightening in both occupancy and rents over the next few quarters as supply is digested and absorption rates remain strong due to expensive housing alternatives. The company continues to manage credit risk proactively, including downgrades and active monetization of challenged assets.

    AI-generated summary of the company’s earnings call. Not investment advice.